Showing results (211-220 of 286) with videos related to
Sort By:
Pageof 29
Journal of Medicine|January 1, 1985
Radiation associated hyperthyroidism in patients with gynecological malignanciesS Katayama, K Shimaoka, M S Piver, et al.Cancer Genetics and Cytogenetics|March 8, 2000
Microsatellite instability in ovarian and other pelvic carcinomasH J Allen, R A DiCioccio, P Hohmann, et al.Cancer|July 1, 1985
Doxorubicin hydrochloride (Adriamycin) cardiotoxicity evaluated by sequential radionuclide angiocardiographyM S Piver, D L Marchetti, K L Parthasarathy, et al.Gynecologic Oncology|October 1, 1989
Adjuvant cisplatin-based chemotherapy for stage I ovarian adenocarcinoma: a preliminary reportM S Piver, J Malfetano, T R Baker, et al.Journal of Cancer Epidemiology|November 30, 2019
Development and Validation of an Algorithm to Identify Endometrial Adenocarcinoma in US Administrative Claims DataD B Esposito, G Banerjee, R Yin, et al.Gynecologic Oncology|December 22, 1999
Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovaryB A Werness, A N Freedman, M S Piver, et al.Cancer|September 1, 1975
Lymphocyte response to autologous tumor antigen(s) and phytohemagglutinin in ovarian cancer patientsM Chatterjee, J J Barlow, H J Allen, et al.Cancer Genetics and Cytogenetics|September 2, 1998
Correlation of TP53 mutations and p53 expression in ovarian tumorsR A DiCioccio, B A Werness, R Peng, et al.Gynecologic Oncology|December 1, 1990
Cisplatin-based chemotherapy for stage II ovarian adenocarcinoma: a preliminary reportM S Piver, J Malfetano, R E Hempling, et al.Gynecologic Oncology|June 1, 1990
Does serum CA-125 level prior to second-look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease?B Patsner, J W Orr, W J Mann, et al.Pageof 29